Literature DB >> 15164876

Therapeutic targeting of the receptor tyrosine kinase Met.

Martin Sattler1, Patrick C Ma, Ravi Salgia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15164876     DOI： 10.1007/1-4020-7847-1_7

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  10 in total

Review 1.  Targeting the HGF/Met signaling pathway in cancer therapy.

Authors:  Fabiola Cecchi; Danie C Rabe; Donald P Bottaro
Journal:  Expert Opin Ther Targets       Date:  2012-04-25       Impact factor: 6.902

2.  Cabozantinib as a novel therapy for renal cell carcinoma.

Authors:  Ulka Vaishampayan
Journal:  Curr Oncol Rep       Date:  2013-04       Impact factor: 5.075

Review 3.  MET molecular mechanisms and therapies in lung cancer.

Authors:  Ryan E Lawrence; Ravi Salgia
Journal:  Cell Adh Migr       Date:  2010-01-16       Impact factor: 3.405

4.  The Hepatocyte Growth Factor Receptor: Structure, Function and Pharmacological Targeting in Cancer.

Authors:  Fabiola Cecchi; Daniel C Rabe; Donald P Bottaro
Journal:  Curr Signal Transduct Ther       Date:  2011

5.  Phase II Study of Cabozantinib in Patients With Bone Metastasis.

Authors:  Edwin Choy; Gregory M Cote; M Dror Michaelson; Lori Wirth; Justin F Gainor; Alona Muzikansky; Lecia V Sequist; Ryan J Sullivan; Panagiotis M Fidias; Alice Shaw; Rebecca S Heist
Journal:  Oncologist       Date:  2022-07-05       Impact factor: 5.837

6.  Differential responsiveness of MET inhibition in non-small-cell lung cancer with altered CBL.

Authors:  Yi-Hung Carol Tan; Tamara Mirzapoiazova; Brian M Won; Li Zhu; Minu K Srivastava; Everett E Vokes; Aliya N Husain; Surinder K Batra; Sherven Sharma; Ravi Salgia
Journal:  Sci Rep       Date:  2017-08-23       Impact factor: 4.379

Review 7.  [Dysregulation of HGF/c-Met signal pathway and their targeting drugs in lung cancer].

Authors:  Yongwen Li; Hongyu Liu; Jun Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-08-20

Review 8.  Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer.

Authors:  Sibi Raj; Kavindra Kumar Kesari; Arun Kumar; Brijesh Rathi; Ashok Sharma; Piyush Kumar Gupta; Saurabh Kumar Jha; Niraj Kumar Jha; Petr Slama; Shubhadeep Roychoudhury; Dhruv Kumar
Journal:  Mol Cancer       Date:  2022-01-26       Impact factor: 27.401

9.  Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer.

Authors:  Manolo D'Arcangelo; Federico Cappuzzo
Journal:  Biologics       Date:  2013-03-03

10.  Downstream signalling and specific inhibition of c-MET/HGF pathway in small cell lung cancer: implications for tumour invasion.

Authors:  P C Ma; M S Tretiakova; V Nallasura; R Jagadeeswaran; A N Husain; R Salgia
Journal:  Br J Cancer       Date:  2007-07-31       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.